|
Volumn 361, Issue 9370, 2003, Pages 1745-1746
|
Recombinant activated factor VII and perioperative blood loss [7]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
RECOMBINANT BLOOD CLOTTING FACTOR 7A;
BLOOD CLOTTING FACTOR 7;
BLOOD CLOTTING FACTOR 7A;
RECOMBINANT PROTEIN;
BLEEDING;
BLOOD TRANSFUSION;
COST EFFECTIVENESS ANALYSIS;
DOSE RESPONSE;
DRUG COST;
DRUG EFFECT;
DRUG MECHANISM;
ERYTHROCYTE CONCENTRATE;
HEMOGLOBIN DETERMINATION;
HEMOSTASIS;
HOSPITALIZATION;
HUMAN;
INTENSIVE CARE;
INTERMETHOD COMPARISON;
LAPAROSCOPIC SURGERY;
LENGTH OF STAY;
LETTER;
MAJOR SURGERY;
OPERATION DURATION;
PERIOPERATIVE PERIOD;
POSTOPERATIVE CARE;
PRIORITY JOURNAL;
PROSTATECTOMY;
SIDE EFFECT;
SURGICAL APPROACH;
SURVIVAL RATE;
THROMBOEMBOLISM;
ECONOMICS;
ERYTHROCYTE TRANSFUSION;
METHODOLOGY;
NOTE;
PRACTICE GUIDELINE;
STANDARD;
BLOOD LOSS, SURGICAL;
ERYTHROCYTE TRANSFUSION;
FACTOR VII;
FACTOR VIIA;
HEMOSTATIC TECHNIQUES;
HUMANS;
LENGTH OF STAY;
PRACTICE GUIDELINES;
PROSTATECTOMY;
RECOMBINANT PROTEINS;
|
EID: 0038324467
PISSN: 01406736
EISSN: None
Source Type: Journal
DOI: 10.1016/S0140-6736(03)13346-6 Document Type: Letter |
Times cited : (8)
|
References (5)
|